A Lawrence Livermore National Laboratory (LLNL)-led team of scientists and computational engineers using one of the largest electronic health record datasets ever assembled for ALS has identified several existing medications that may be associated with […]
In a phase 3 clinical trial, the tetravalent dengue vaccine, developed by the Butantan Institute in São Paulo, Brazil, was 80.5% effective against severe dengue cases with warning signs over a five-year period. The results […]
The first clinical trial to compare two commonly used drugs head-to-head for venous thrombosis treatment has found a clear winner: while both drugs work well to prevent recurrent blood clots, apixaban is safer than rivaroxaban, […]
Sildenafil—an active ingredient also marketed under the name of Viagra—improves symptoms in patients with Leigh syndrome. This has now been reported in the journal Cell by researchers at Charité—Universitätsmedizin Berlin, together with teams from Heinrich […]
The U.S. Food and Drug Administration has approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.This article was originally published on MedicalXpress.com
Medicinal cannabis could provide a new treatment option for those with endometriosis, with a study led by the University of Otago, Wellington showing it reduced pain, improved sleep and lowered anxiety. The study, led by […]
Managing complex medical conditions often requires the simultaneous use of multiple different drugs, referred to as polypharmacy. While necessary, this significantly increases the risk of drug-drug interactions (DDIs), which can either enhance or decrease therapeutic […]
A team of Taiwanese researchers have used a nationwide, population-based cohort to examine whether taking acetaminophen during pregnancy might be linked to a higher likelihood of attention-deficit/hyperactivity disorder (ADHD) or autism spectrum disorders (ASDs) in […]
Patients without diabetes who switched GLP-1 receptor agonist (GLP-1RA) drugs for overweight or obesity were more likely to stick with their treatment longer than those who didn’t switch, according to a new study by UT […]
Wegovy, a GLP-1 agonist for weight loss, may carry the highest risk of “eye stroke” (ischemic optic neuropathy) and sudden sight loss of the semaglutide drugs, finds an analysis of unintended side effect reports published […]
© 2025 SimplyWell.ca